ATE447399T1 - Impfstoffvorläufer, impfstoffe zur behandlung von krebs - Google Patents
Impfstoffvorläufer, impfstoffe zur behandlung von krebsInfo
- Publication number
- ATE447399T1 ATE447399T1 AT98901030T AT98901030T ATE447399T1 AT E447399 T1 ATE447399 T1 AT E447399T1 AT 98901030 T AT98901030 T AT 98901030T AT 98901030 T AT98901030 T AT 98901030T AT E447399 T1 ATE447399 T1 AT E447399T1
- Authority
- AT
- Austria
- Prior art keywords
- antibodies
- antitoxins
- vaccines
- agents
- molecular
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP02829597A JP3813682B2 (ja) | 1997-01-29 | 1997-01-29 | ワクチン前駆体およびワクチン |
PCT/JP1998/000351 WO1998032431A1 (fr) | 1997-01-29 | 1998-01-28 | Inducteurs antigenes, precurseurs de vaccin, vaccins, anticorps, anticorps neutralisants, antitoxines, anticorps idiotypiques, et anticorps anti-idiotypiques induits par lesdits anticorps idiotypiques |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE447399T1 true ATE447399T1 (de) | 2009-11-15 |
Family
ID=12244637
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT98901030T ATE447399T1 (de) | 1997-01-29 | 1998-01-28 | Impfstoffvorläufer, impfstoffe zur behandlung von krebs |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP1004299B1 (de) |
JP (1) | JP3813682B2 (de) |
AT (1) | ATE447399T1 (de) |
AU (1) | AU5678698A (de) |
CA (1) | CA2279196C (de) |
DE (1) | DE69841271D1 (de) |
WO (1) | WO1998032431A1 (de) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8409564B2 (en) | 1999-10-05 | 2013-04-02 | Universite De Montreal | Rhodamine derivatives for photodynamic diagnosis and treatment |
CA2548468C (en) * | 2003-12-05 | 2012-05-29 | Universite De Montreal | The use of dead cell material obtained from rhodamine-based photodynamic therapy in the treatment or prevention of immunologic disorders, infections and cancers |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE345786T1 (de) * | 1994-09-09 | 2006-12-15 | Shozo Koyama | Mittel zum herabsetzen von molekülfunktionen |
JP4435304B2 (ja) * | 1995-06-29 | 2010-03-17 | イミュネックス・コーポレーション | アポトーシスを誘導するサイトカイン |
JPH09221421A (ja) * | 1996-02-13 | 1997-08-26 | Kyowa Hakko Kogyo Co Ltd | 抗アポトーシス剤 |
-
1997
- 1997-01-29 JP JP02829597A patent/JP3813682B2/ja not_active Expired - Fee Related
-
1998
- 1998-01-28 AU AU56786/98A patent/AU5678698A/en not_active Abandoned
- 1998-01-28 EP EP98901030A patent/EP1004299B1/de not_active Expired - Lifetime
- 1998-01-28 CA CA2279196A patent/CA2279196C/en not_active Expired - Fee Related
- 1998-01-28 AT AT98901030T patent/ATE447399T1/de not_active IP Right Cessation
- 1998-01-28 DE DE69841271T patent/DE69841271D1/de not_active Expired - Lifetime
- 1998-01-28 WO PCT/JP1998/000351 patent/WO1998032431A1/ja active Application Filing
Also Published As
Publication number | Publication date |
---|---|
JP3813682B2 (ja) | 2006-08-23 |
CA2279196A1 (en) | 1998-07-30 |
DE69841271D1 (de) | 2009-12-17 |
WO1998032431A1 (fr) | 1998-07-30 |
EP1004299B1 (de) | 2009-11-04 |
EP1004299A1 (de) | 2000-05-31 |
AU5678698A (en) | 1998-08-18 |
CA2279196C (en) | 2011-11-01 |
JPH10212229A (ja) | 1998-08-11 |
EP1004299A4 (de) | 2004-01-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES500567A0 (es) | Procedimiento de preparar complejos vacunantes por reaccion de arn ribonosales y de antigenos especificos. | |
BR0206565A (pt) | Arranjo de antìgeno molecular | |
DE69233435D1 (de) | Vorläufer von für tumorabstossung verantwortlichen antigenen, die antigene und deren verwendungen | |
HUP0303199A2 (hu) | Eljárás T-sejt-epitópok azonosítására és csökkentett immunogenitású molekulák előállítására | |
FI956019A (fi) | Eristettyjä peptidejä, jotka muodostavat komplekseja MHC-molekyyli HLA-C-klooni-10:n kanssa, ja niiden käyttö | |
DE69936784D1 (de) | Behandlung von gebärmutterhalskrebs | |
FI960268A (fi) | Menetelmä sairauden diagnosoimiseksi määrittämällä GAGE-tuumorihyljintäantigeenin prekursorien ilmentymistä | |
DE69927262D1 (de) | Cd40 bindende antikörper und ctl peptide zur behandlung von tumoren | |
ATE535254T1 (de) | Behandlung von krebs mit dem anti-erbb2- antikörper rhumab 2c4 | |
DK1103564T3 (da) | Cancerantigener baseret på tumorsuppressorgen WT1-produkt | |
DE3789082D1 (de) | Expression eines tumorspezifischen Antigens eines rekombinanten Virusvektors sowie dessen Anwendung zur versorgenden oder heilenden Behandlung des entsprechenden Tumors. | |
DE69032816T2 (de) | Verwendung von oncostatin m zur suppression von mhc antigenen | |
ATE391726T1 (de) | Modifiziertes gp100 und dessen verwendung | |
DE59309239D1 (de) | Verfahren zur Isolierung und Kultivierung von transformierten Zellen sowie Verwendung dieser Zellen zur Herstellung individuumsspezifischer Antikörper | |
DE69841271D1 (de) | Impfstoffvorläufer, impfstoffe zur behandlung von krebs | |
NZ302821A (en) | isolated truncated nucleic acid molecules which code for GAGE tumour rejection antigen precursors | |
DE69832804D1 (de) | Verfahren zur herstellung von katalytischen antikörpern | |
FI924222A0 (fi) | Gp75 som ett tumoervaccin mot melanoma. | |
ATE369895T1 (de) | Modifizierte cea nucleinsäure und expressionsvektoren | |
ATE396742T1 (de) | Komplexe mit adjuvanter wirkung | |
HUP0301725A2 (hu) | Új vegyületek és eljárások | |
ATE313551T1 (de) | Isoliertes nukleinsäuremolekül, das die tumorabstossungs-antigenvorläufer mage- c1 und mage-c2 kodiert und seine verwendung | |
ATE160359T1 (de) | Antigene regionen von tumorfreigestzten partikeln (tlp) komplexen und antikörper die sie erkennen. | |
EA200300638A1 (ru) | Вакцинная композиция, содержащая трансформирующий фактор роста альфа | |
FI924576A (fi) | Ctaa 28a32, antigen identiefierad av mca 28a32 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |